Effects of heterochromatin in colorectal cancer stem cells on radiosensitivity

Chinese Journal of Cancer

Volumn 29, Issue 3, 2010, Pages 270-276

  Chen, Ting ^a   Zhang, Yu ^a   Guo, Wen Hao ^a   Meng, Mao Bin ^a   Mo, Xian Ming ^a   Lu, You ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cancer stem cell; Colorectal neoplasm; Heterochromatin; High single dose radiation; Radioresistance

Indexed keywords

CD133 ANTIGEN; HETEROCHROMATIN PROTEIN 1; HISTONE H3;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CANCER STEM CELL; CELL NUCLEUS; CHROMATIN STRUCTURE; CHROMOSOME STRUCTURE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; EUCHROMATIN; FEMALE; HETEROCHROMATIN; HISTONE MODIFICATION; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; RADIOSENSITIVITY; TUMOR XENOGRAFT;

EID: 79955798056     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10694     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statisties, 2002 [J]. CA Cancer J Clin, 2005,55(2):74-108.
2. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells [J]. Nature, 2001, 414(6859): 105-111.
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells [J]. Proc Natl Acad Sci U S A, 2003, 100(7): 3983-3988.
4. Kondo T. Brain cancer stem-like cells [J]. Eur J Cancer, 2006, 42(9): 1237-1242.
5. Eramo A, Lotti F, Sette G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population [J]. Cell Death Differ, 2008, 15(3): 504-514.
6. O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice [J]. Nature, 2007, 445(7123): 106-110.
7. Kang MK, Kang SK. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma [J]. Stem Cells Dev, 2007, 16(5): 837-847.
8. + HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway [J]. Oncogene, 2008, 27(12): 1749-1758.
9. Abbott A. Cancer: the root of the problem [J]. Nature, 2006, 442(7104): 742-743.
10. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J]. Nature, 2006, 444(7120): 756-760.
11. + breast cancer-initiating cells to radiation [J]. J Natl Cancer Inst, 2006, 98 (24): 1777-1785.
12. Rich JN. Cancer stem cells in radiation resistance [J]. Cancer Res, 2007, 67(19): 8980-8984.
13. + sector is enlarged by hypoxia [J]. Int J Radiat Oncol Biol Phys, 2007,67(1):1-5.
14. Bannister AJ, Kouzarides T. Reversing histone methylation [J]. Nature, 2005, 436(7054): 1103-1106.
15. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance [J]. Nat Rev Cancer, 2008, 8(7): 545-554.
16. Stucki M, Clapperton JA, Mohammad D, et al. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks [J]. Cell, 2005, 123(7): 1213-1226.
17. Dillon N. Heterochromatin structure and function [J]. Biol Cell, 2004, 96 (8): 631-637.
18. Cowell IG, Aucott R, Mahadevaiah SK, et al. Heterochromatin, HP1 and methylation at lysine 9 of histone H3 in animals [J]. Chromosoma, 2002, 111(1): 22-36.
19. Nielsen PR, Nietlispach D, Mott HR, et al. Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9 [J]. Nature, 2002, 416(6876): 103-107.
20. Li F, Huarte M, Zaratiegui M, et al. Lid2 is required for coordinating H3K4 and H3K9 methylation of heterochromatin and euchromatin [J]. Cell, 2008, 135(2): 272-283.
21. Camphausen K, Tofilon PJ. Inhibition of histone deacetylation: a strategy for tumor radiosensitization [J]. J Clin Oncol, 2007, 25(26): 4051-4056.
22. Georgetown University. Methods for the use of inhibitors of histone deacetylase as synergistic agents in cancer therapy [P]. US2005222013 (A1), 2005.
23. Sloan Kettering Institute for Cancer Research. Combination therapy for the treatment of cancer [P]. EP1501489(A1), 2005.
24. Kim IA, Shin JH, Kim IH, et al. Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53 [J]. Clin Cancer Res, 2006, 12 (3 Pt 1): 940-949.